MICROBOT MEDICAL INC. Net Income (Loss) Available to Common Stockholders, Basic
MICROBOT MEDICAL INC. (MBOT) reported Net Income (Loss) Available to Common Stockholders, Basic of $7.25 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-04-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2020-04-14
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-12-31 was $11.89M, a 12.53% increase year-over-year.
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-09-30 was -$1.71M.
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-06-30 was -$1.82M.
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-03-31 was $1.37M, a 4.51% increase year-over-year.
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for fiscal 2019 was $7.25M, a 3.44% increase from fiscal 2018.
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for fiscal 2018 was $7.01M, a 16.63% increase from fiscal 2017.
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for fiscal 2017 was $6.01M, a 5.22% increase from fiscal 2016.
- MICROBOT MEDICAL INC. net income (loss) available to common stockholders, basic for fiscal 2016 was $5.71M, a 917.65% increase from fiscal 2015.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | $7.25M 10-K · filed 2020-04-14 | |||||
| 2018-12-31 | $11.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14 | $10.18M derived: sum of 2 quarters · filed 2020-04-14 | $8.37M derived: sum of 3 quarters · filed 2020-04-14 | $7.01M 10-K · filed 2020-04-14 | $6.99M 10-K · filed 2019-04-01 | |
| 2018-09-30 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$3.52M derived: sum of 2 quarters · filed 2018-11-14 | -$4.88M 10-Q · filed 2018-11-14 | $8.41M derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2018-06-30 | -$1.82M 10-Q · filed 2018-08-14 | -$3.18M 10-Q · filed 2018-08-14 | $10.12M derived: sum of 3 quarters · filed 2019-04-01 | $9.16M derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2018-03-31 | $1.37M 10-Q · filed 2018-05-15 | $11.93M derived: sum of 2 quarters · filed 2019-04-01 | $10.98M derived: sum of 3 quarters · filed 2019-04-01 | $8.41M derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2017-12-31 | $10.57M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $9.61M derived: sum of 2 quarters · filed 2019-04-01 | $7.04M derived: sum of 3 quarters · filed 2019-04-01 | $6.01M 10-K · filed 2019-04-01 | ||
| 2017-09-30 | -$953.00K 10-Q · filed 2017-11-14 | -$3.52M derived: sum of 2 quarters · filed 2018-08-14 | -$4.56M 10-Q · filed 2018-11-14 | $4.64M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-06-30 | -$2.57M 10-Q · filed 2018-08-14 | -$3.54M 10-Q · filed 2018-08-14 | $4.82M 10-Q · filed 2017-08-14 | $5.59M derived: sum of 3 quarters · filed 2018-08-14 | $5.23M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $1.31M 10-Q · filed 2018-05-15 | $8.16M derived: sum of 2 quarters · filed 2018-05-15 | $7.80M derived: sum of 3 quarters · filed 2018-05-15 | $8.08M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $6.50M derived: sum of 2 quarters · filed 2018-04-02 | $6.77M derived: sum of 3 quarters · filed 2018-04-02 | $5.71M 10-K · filed 2018-04-02 | ||
| 2016-09-30 | -$355.00K 10-Q · filed 2017-11-14 | -$81.00K derived: sum of 2 quarters · filed 2017-11-14 | -$1.14M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $440.00K 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | $166.00K 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | $561.00K 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |